As shown in Fig. 1E, higher NCS‐1 expression correlates with a poorer OS in the basal breast cancer patient subgroup (HR = 3.15, P = 0.0002), further implicating the significance of NCS‐1 in basal breast cancers. This evidence concerns the gene NCS1 and breast carcinoma.